These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Association between the Presence of Aminoglycoside-Modifying Enzymes and In Vitro Activity of Gentamicin, Tobramycin, Amikacin, and Plazomicin against Klebsiella pneumoniae Carbapenemase- and Extended-Spectrum-β-Lactamase-Producing Enterobacter Species. Haidar G; Alkroud A; Cheng S; Churilla TM; Churilla BM; Shields RK; Doi Y; Clancy CJ; Nguyen MH Antimicrob Agents Chemother; 2016 Sep; 60(9):5208-14. PubMed ID: 27297487 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of the Bactericidal Activity of Plazomicin and Comparators against Multidrug-Resistant Enterobacteriaceae. Thwaites M; Hall D; Shinabarger D; Serio AW; Krause KM; Marra A; Pillar C Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29866876 [TBL] [Abstract][Full Text] [Related]
5. Nationwide epidemiology of carbapenem resistant Klebsiella pneumoniae isolates from Greek hospitals, with regards to plazomicin and aminoglycoside resistance. Galani I; Nafplioti K; Adamou P; Karaiskos I; Giamarellou H; Souli M; BMC Infect Dis; 2019 Feb; 19(1):167. PubMed ID: 30770727 [TBL] [Abstract][Full Text] [Related]
6. In vitro activity of the next-generation aminoglycoside plazomicin alone and in combination with colistin, meropenem, fosfomycin or tigecycline against carbapenemase-producing Enterobacteriaceae strains. Rodríguez-Avial I; Pena I; Picazo JJ; Rodríguez-Avial C; Culebras E Int J Antimicrob Agents; 2015 Dec; 46(6):616-21. PubMed ID: 26391381 [TBL] [Abstract][Full Text] [Related]
7. Carbapenem-resistant Klebsiella pneumoniae strains exhibit diversity in aminoglycoside-modifying enzymes, which exert differing effects on plazomicin and other agents. Almaghrabi R; Clancy CJ; Doi Y; Hao B; Chen L; Shields RK; Press EG; Iovine NM; Townsend BM; Wagener MM; Kreiswirth B; Nguyen MH Antimicrob Agents Chemother; 2014 Aug; 58(8):4443-51. PubMed ID: 24867988 [TBL] [Abstract][Full Text] [Related]
8. Activity of plazomicin in combination with other antibiotics against multidrug-resistant Enterobacteriaceae. Thwaites M; Hall D; Stoneburner A; Shinabarger D; Serio AW; Krause KM; Marra A; Pillar C Diagn Microbiol Infect Dis; 2018 Dec; 92(4):338-345. PubMed ID: 30097297 [TBL] [Abstract][Full Text] [Related]
10. Activity of a novel aminoglycoside, ACHN-490, against clinical isolates of Escherichia coli and Klebsiella pneumoniae from New York City. Landman D; Babu E; Shah N; Kelly P; Bäcker M; Bratu S; Quale J J Antimicrob Chemother; 2010 Oct; 65(10):2123-7. PubMed ID: 20667885 [TBL] [Abstract][Full Text] [Related]
11. Antimicrobial activity of plazomicin against Enterobacteriaceae-producing carbapenemases from 50 Brazilian medical centers. Martins AF; Bail L; Ito CAS; da Silva Nogueira K; Dalmolin TV; Martins AS; Rocha JLL; Serio AW; Tuon FF Diagn Microbiol Infect Dis; 2018 Mar; 90(3):228-232. PubMed ID: 29223516 [TBL] [Abstract][Full Text] [Related]
12. Pharmacodynamics of plazomicin and a comparator aminoglycoside, amikacin, studied in an in vitro pharmacokinetic model of infection. Noel AR; Attwood M; Bowker KE; Kim A; Krause KM; MacGowan AP Int J Antimicrob Agents; 2019 Nov; 54(5):626-632. PubMed ID: 31299297 [TBL] [Abstract][Full Text] [Related]
13. In vitro susceptibility to 19 agents other than β-lactams among third-generation cephalosporin-resistant Enterobacteriaceae recovered on hospital admission. Mischnik A; Baumert P; Hamprecht A; Rohde AM; Peter S; Feihl S; Knobloch J; Gölz H; Kola A; Obermann B; Querbach C; Willmann M; Gebhardt F; Tacconelli E; Gastmeier P; Seifert H; Kern WV; J Antimicrob Chemother; 2017 May; 72(5):1359-1363. PubMed ID: 28108677 [TBL] [Abstract][Full Text] [Related]
14. In vitro activity of plazomicin compared to other clinically relevant aminoglycosides in carbapenem-resistant Enterobacteriaceae. Clark JA; Kulengowski B; Burgess DS Diagn Microbiol Infect Dis; 2020 Oct; 98(2):115117. PubMed ID: 32755805 [TBL] [Abstract][Full Text] [Related]
16. In vitro activity of plazomicin against β-lactamase-producing carbapenem-resistant Enterobacteriaceae (CRE). Zhang Y; Kashikar A; Bush K J Antimicrob Chemother; 2017 Oct; 72(10):2792-2795. PubMed ID: 29091224 [TBL] [Abstract][Full Text] [Related]
17. In Vitro Activity of Plazomicin Against Carbapenem Resistant Klebsiella pneumoniae Strains. Demirbas Z; Ozger HS; Suzuk-Yildiz S; Bakkaloglu Z; Dizbay M Clin Lab; 2022 Jun; 68(6):. PubMed ID: 35704736 [TBL] [Abstract][Full Text] [Related]
18. Confronting Ceftolozane-Tazobactam Susceptibility in Multidrug-Resistant Enterobacterales Isolates and Whole-Genome Sequencing Results (STEP Study). Hernández-García M; García-Fernández S; García-Castillo M; Melo-Cristino J; Pinto MF; Gonçalves E; Alves V; Costa E; Ramalheira E; Sancho L; Diogo J; Ferreira R; Silva T; Chaves C; Pássaro L; Paixão L; Romano J; Cantón R; Int J Antimicrob Agents; 2021 Feb; 57(2):106259. PubMed ID: 33310115 [TBL] [Abstract][Full Text] [Related]
19. [Antimicrobial effectiveness of sisomicin. I: In vitro activity of sisomicin compared with gentamicin, tobramycin, amikacin and kanamycin (author's transl)]. Schassan HH Infection; 1976; 4(2):35-41. PubMed ID: 789246 [TBL] [Abstract][Full Text] [Related]
20. Comparison of in vitro activities of plazomicin and other aminoglycosides against clinical isolates of Klebsiella pneumoniae and Escherichia coli. İnce G; Mirza HC; Üsküdar Güçlü A; Gümüş H; Erol Ç; Başustaoğlu A J Antimicrob Chemother; 2021 Nov; 76(12):3192-3196. PubMed ID: 34499728 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]